The booming monoclonal antibody contract manufacturing market, valued at $25B in 2025, is projected to reach $63B by 2033, driven by rising demand for biologics and technological advancements. Explore market trends, key players (Lonza, Merck KGaA, etc.), and regional analysis in this comprehensive report.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.